AC Immune (ACIU) Interest Coverage Ratio Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | -36.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.58% |
| Dec 31, 2025 | 39.25% |
| Sep 30, 2025 | 259.55% |
| Jun 30, 2025 | -37.10% |
| Mar 31, 2025 | 162.56% |
| Dec 31, 2024 | -514.25% |
| Sep 30, 2024 | -137.03% |
| Jun 30, 2024 | -2.35% |
| Mar 31, 2024 | -416.53% |
| Dec 31, 2023 | 100.73% |
| Sep 30, 2023 | 240.22% |
| Jun 30, 2023 | 300.56% |
| Mar 31, 2023 | 48.15% |
| Dec 31, 2022 | -47,361.47% |
| Sep 30, 2022 | 56.03% |
| Jun 30, 2022 | 70.35% |
| Mar 31, 2022 | -98.58% |
| Dec 31, 2021 | -94.92% |
| Sep 30, 2021 | -72.59% |
| Jun 30, 2021 | -66.97% |
| Mar 31, 2021 | 372.50% |
| Dec 31, 2020 | 7.55% |
| Sep 30, 2020 | 295.57% |
| Jun 30, 2020 | 855.62% |
| Mar 31, 2020 | 109.10% |
| Dec 31, 2019 | 1,753.88% |
| Sep 30, 2019 | -153.24% |
| Jun 30, 2019 | -94.43% |
| Mar 31, 2019 | -2,202.38% |
| Dec 31, 2018 | 2,451.96% |
| Sep 30, 2018 | 18,597.52% |
| Jun 30, 2018 | 8,108.09% |
| Mar 31, 2018 | -18,265.54% |
| Dec 31, 2017 | 101.49% |
| Sep 30, 2017 | -72.41% |
| Mar 31, 2017 | -99.75% |
| Dec 31, 2016 | -143.96% |
| Sep 30, 2016 | 102.09% |